Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Everest Medicines Limited
  6. Company
    1952   KYG3224E1061

EVEREST MEDICINES LIMITED

(1952)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Everest Medicines Ltd is a China-based company principally engaged in the licensing, clinical development and commercialization of therapies to address critical unmet medical needs. The Company is focusing on the research and development of innovative drug candidate. The Company built a portfolio of promising clinical-stage drug candidates across oncology, immunology, cardio-renal disease and infectious disease. The Company mainly provides its products and services in Greater China and other emerging Asia Pacific markets.

Number of employees : 149 people.
Managers
Name Title Age Since
Kerry Levan Blanchard, Dr. Chief Executive Officer & Executive Director 65 2020
Ian Ying Woo President, CFO & Executive Director 48 2018
Jennifer Yang, Dr. Chief Scientific Officer - 2021
Xiaofan Zhang Chief Operating Officer & Executive Director 37 2017
Bo Tan Independent Non-Executive Director 48 -
Yi Fan Li Independent Non-Executive Director 53 2020
Shidong Jiang Independent Non-Executive Director 53 -
Yin Yin Joint Secretary & Head-Investor Relations 49 -
Yee Wa Lau Joint Secretary 48 -
Jason M. Brown, Dr. Senior Vice President-Business Development 49 2017
Members of the board
Name Title Age Since
Wei Fu Chairman 38 2017
Kerry Levan Blanchard, Dr. Chief Executive Officer & Executive Director 65 2020
Ian Ying Woo President, CFO & Executive Director 48 2018
Yu Bo Gong Non-Executive Director 36 2020
Bo Tan Independent Non-Executive Director 48 -
Yi Fan Li Independent Non-Executive Director 53 2020
Shidong Jiang Independent Non-Executive Director 53 -
Xiaofan Zhang Chief Operating Officer & Executive Director 37 2017
Lan Kang Non-Executive Director 52 2020
Shareholders
NameEquities%
Shanghai Kangshiqiao Business Consulting Co. Ltd. 103,639,823 34.7%
Wei Fu 24,005,392 8.05%
RA Capital Management LP 21,162,033 7.09%
Janchor Partners Ltd. 17,421,444 5.84%
Wellington Management Co. LLP 16,328,029 5.47%
Janus Capital Management LLC 2,922,566 0.98%
GIC Pte Ltd. (Investment Management) 2,818,000 0.94%
The Vanguard Group, Inc. 2,466,989 0.83%
BlackRock Advisors LLC 2,063,500 0.69%
Columbia Management Investment Advisers LLC 1,798,000 0.60%
Company contact information
Everest Medicines Ltd.
Harbour Place
103 South Church Street
4th Floor
George Town KY1-1002

Web : http://www.everestmedicines.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Everest Medicines Limited